Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALLAS: Palbociclib in HR+/HER2- Early Breast Cancer
NCT02513394Phase 3Active, not recruiting
- Sponsor
- Alliance Foundation Trials
- Start
- Aug 2015
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of palbociclib in breast cancer, sponsored by Alliance Foundation Trials. Started Aug 2015; status: active, not recruiting.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02513394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513394.